Patent Licensing Marketplace
Arrhythmia Technology Patents
Verified patents from USPTO covering PFA, wearables, AI diagnostics, and cardiac mapping
30
Patents Listed
7
PFA Patents
6
Opportunities
Patent data sourced from USPTO and Google Patents. Licensing status is indicative only - contact assignees directly for current availability. ArrHub provides brokerage services but does not own these patents.
Showing 30 patents
3D ECG Technology for Remote Cardiac Monitoring
Credit card-sized device capturing high-fidelity electrical signals from three noncoplanar directions for 12-lead ECG synthesis, with rhythm analysis algorithm for detecting sinus rhythm, atrial fibrillation, and other arrhythmias.
HeartBeam holds 20+ patents with 32 pending. Public company (NASDAQ: BEAT) seeking partnerships. FDA clearance Dec 2024.
Methods of Ventricular Arrhythmia Localization Using a 3D Model
Method for ventricular arrhythmia localization using a 3D model, part of VIVO technology intellectual property portfolio for cardiac ventricular therapies.
Catheter Precision actively seeking partners. Recently announced USPTO allowance Sept 2025.
Pulsed Field Ablation Medical System
A medical system including a medical device having a plurality of deployable arms with electrodes, and an electric signal generator programmed to deliver pulsed energy sufficient to induce irreversible electroporation ablation.
Recent Medtronic PFA patent. Contact Medtronic Ablation Frontiers for licensing.
Implant-to-Implant Communication in Multi-Device Cardiac System
Systems and methods for communication between multiple implantable cardiac devices using conductive body tissue for signal transmission enabling synchronized pacing.
Core i2i technology enabling AVEIR DR dual-chamber leadless pacing.
Leadless Dual-Chamber Pacemaker System (AVEIR DR)
Dual-chamber leadless pacemaker system with i2i (implant-to-implant) communication technology enabling beat-to-beat synchronization between two leadless pacemakers using high-frequency pulses via body conduction.
Core Abbott technology - world's first dual-chamber leadless pacemaker (FDA approved July 2023). Strategic IP.
Systems, Apparatuses and Methods for Delivery of Ablative Energy to Tissue
A system includes a pulse waveform generator and an ablation device coupled to the pulse waveform generator. The ablation device includes at least one electrode configured for ablation pulse delivery to tissue during use with hierarchical pulse waveforms.
Core FARAPULSE technology. Originally Farapulse Inc., acquired by Boston Scientific in 2022 for $925M. Contact Boston Scientific IP.
Discordance Monitoring
Analysis of heart rate data and activity data from wearable devices to trigger notifications when there is discordance between biometrics, potentially indicating asymptomatic atrial fibrillation.
SmartRhythm technology patent. Subject of Apple litigation. Contact AliveCor.
Methods and Systems for Arrhythmia Tracking and Scoring
Methods and systems for tracking arrhythmia using ECG data from portable devices. The system analyzes heart rate data to detect atrial fibrillation and other arrhythmias, providing scoring and tracking capabilities.
Part of AliveCor's KardiaMobile portfolio. Subject of Apple litigation (2020-2024). Contact AliveCor for licensing.
Cardiac Pulsed Field Ablation
A method for ablating tissue by applying at least one pulse train of pulsed-field energy. The method includes delivering a pulse train of energy having a predetermined frequency to cardiac tissue, with biphasic pulses that reduce post-ablation depolarization and overcome high impedance characteristics of fatty cells.
Core PFA technology for Medtronic PulseSelect system. Contact Medtronic IP department for licensing inquiries.
Systems, Devices, and Methods for Delivery of Pulsed Electric Field Ablative Energy to Endocardial Tissue
Systems, devices, and methods for electroporation ablation therapy, with the system including a pulse waveform signal generator for medical ablation therapy, and an endocardial ablation device with electrodes for ablation pulse delivery synchronized with cardiac pacing signals.
Key patent in FARAPULSE portfolio. Contact Boston Scientific for licensing.
Leadless Pacemaker System
System and method for leadless cardiac pacing including intracardiac device with sensing, pacing, and communication capabilities without transvenous leads.
Foundational Micra leadless pacemaker patent. Core Medtronic IP.
Subcutaneous Implantable Cardioverter-Defibrillator
Subcutaneous ICD system with electrode placement entirely outside the ribcage, eliminating need for transvenous leads while providing defibrillation therapy.
Foundational S-ICD patent. Boston Scientific acquired Cameron Health in 2012. EMBLEM S-ICD heritage.
Deep Learning for ECG Analysis and Cardiac Dysfunction Detection
Deep neural network system for analyzing ECG signals to detect left ventricular dysfunction and other cardiac abnormalities from standard 12-lead recordings.
HeartSciences (NASDAQ: HSCS) AI-ECG portfolio. Public company seeking partnerships.
High-Voltage Pulse Ablation Systems and Methods
Systems and methods for administering minimally invasive stand-alone atrial fibrillation therapy using bipolar clamping technology and high-voltage pulses as a non-thermal means of ablating tissue.
Patent approaching mid-life. AtriCure may consider licensing for non-competing applications.
Systems for Detecting Cardiac Arrhythmias
Methods for detecting atrial fibrillation and atrial flutter using local heart rate measurements that account for common confounding ectopy, employing measurements of RR variability while avoiding effects of single-focus ectopic arrhythmia.
Patent nearing expiration (2028). iRhythm may consider licensing for remaining term.
Systems and Methods for Cardiac Tissue Electroporation Ablation
Cardiac electroporation ablation systems and methods in which pulsed, high voltage energy is delivered to induce electroporation of cells of cardiac tissue followed by cell rupturing using biphasic energy.
Early electroporation patent nearing expiration (2028). May be available for licensing. Now owned by Abbott.
Cardiac Pulsed Field Ablation Method
Method for ablating cardiac tissue using pulsed field energy with specific pulse train parameters including voltage, frequency, and timing synchronized to cardiac cycle.
Continuation patent in active PulseSelect family. Core PFA technology.
Wearable Device with Electrodes for Physiological Measurements
Electronic wearable device with electrodes capable of taking physiological measurements including ECG when worn on or coupled to a body of user, with dual-purposed electrodes for multiple types of measurements.
Apple Watch ECG technology. Apple rarely licenses core IP but may consider for specific applications.
Pulsed Field Ablation Catheter with Electrode Array
Ablation catheter with multiple electrodes configured for pulsed field ablation delivery integrated with electroanatomical mapping capabilities.
Part of Varipulse PFA system portfolio. J&J/Biosense Webster strategic IP.
Medical System for Pulsed Field Ablation
A method and system for mapping tissue and producing lesions for treatment of cardiac arrhythmias in a non-thermal and optimal manner, minimizing energy required to selectively ablate target tissues with timing optimization.
Combined mapping and PFA technology. Contact Medtronic.
Implantable Cardiac Monitor with Smartphone Connectivity
Insertable cardiac monitor with direct smartphone connectivity for patient-triggered recordings and automatic data transmission to clinical systems.
Confirm Rx ICM smartphone connectivity technology. BlueSync platform.
Ultra-High Density Mapping with Automatic Annotation
System for ultra-high density electroanatomical mapping with automatic signal annotation and real-time map construction during ablation procedures.
RHYTHMIA HDx mapping system technology. IntellaMap ORION catheter support.
Methods for Detection and Analysis of Cardiac Arrhythmias
Machine learning algorithms for continuous ambulatory ECG analysis with automated arrhythmia detection and classification using patch monitor data.
Zio platform AI technology. iRhythm core diagnostic IP.
Leadless Pacemaker Delivery System with Balloon Stabilization
Catheter-based delivery system for leadless pacemaker with inflatable balloon for tissue contact stabilization during deployment.
Micra delivery system technology. Supports safe device implantation.
High-Density Cardiac Mapping with Omnipolar Technology
Methods for high-resolution cardiac mapping using omnipolar electrograms that provide direction-independent signal measurement for improved substrate characterization.
EnSite X EP System core technology. Omnipolar mapping for direction-independent signals.
Subcutaneous ICD Signal Processing with SMART Pass Filter
Signal processing algorithms for subcutaneous ICD with SMART Pass filtering to reduce inappropriate shocks from T-wave oversensing.
SMART Pass technology reducing inappropriate shocks. EMBLEM MRI S-ICD feature.
Remote Cardiac Monitoring System with Alert Management
System for remote monitoring of implantable cardiac devices with intelligent alert prioritization and clinical workflow management.
CareLink remote monitoring platform technology. Supports LINQ and pacemaker monitoring.
Discordance Monitoring
Use of data collected from wearable devices as a means of assisting the diagnosis of heart arrhythmias, including those that may be asymptomatic, by detecting disagreement between heart rate and activity levels.
Original SmartRhythm patent. Contact AliveCor for licensing inquiries.
Methods and Systems for Arrhythmia Tracking and Scoring
System for tracking arrhythmias over time using portable ECG device data with scoring algorithms to assess patient cardiac health trends.
Part of KardiaMobile portfolio. Subject of Apple litigation (2020-2024). PTAB invalidated claims.
Methods for Subcutaneous ICD Electrode Positioning
Methods and systems for optimal positioning of subcutaneous electrode in S-ICD systems using anatomical landmarks and sensing verification.
S-ICD implant methodology patent. Supports EMBLEM S-ICD procedures.
Need Patent Licensing Assistance?
ArrHub offers professional patent brokerage services for the arrhythmia device industry with 30+ years of medical device IP experience.
- Patent search & due diligence
- Licensing negotiation support
- Portfolio analysis & valuation
- Technology landscape mapping
patents@arrhub.com
Verified Patent Data Sources
All patent information is sourced from official USPTO records and verified against Google Patents. Patent numbers, grant dates, and assignee information are accurate as of the dates shown.